We undertook a randomised prospective follow-up study of changes in peri-prosthetic bone mineral density (BMD) after hip resurfacing and compared them with the results after total hip replacement. A total of 59 patients were allocated to receive a hip resurfacing (n = 29) or an uncemented distally fixed total hip replacement (n = 30). The BMD was prospectively determined in four separate regions of interest of the femoral neck and in the calcar region corresponding to Gruen zone 7 for the hip resurfacing group and compared only to the calcar region in the total hip replacement group. Standardised measurements were performed pre-operatively and after three, six and 12 months. The groups were well matched in terms of gender distribution and mean age.
We undertook a randomised prospective follow-up study of changes in peri-prosthetic bone mineral density (BMD) after hip resurfacing and compared them with the results after total hip replacement. A total of 59 patients were allocated to receive a hip resurfacing (n = 29) or an uncemented distally fixed total hip replacement (n = 30). The BMD was prospectively determined in four separate regions of interest of the femoral neck and in the calcar region corresponding to Gruen zone 7 for the hip resurfacing group and compared only to the calcar region in the total hip replacement group. Standardised measurements were performed pre-operatively and after three, six and 12 months. The groups were well matched in terms of gender distribution and mean age.
The mean BMD in the calcar region increased after one year to 105.2% of baseline levels in the resurfaced group compared with a significant decrease to 82.1% in the total hip replacement group (p < 0.001) by 12 months. For the resurfaced group, there was a decrease in bone density in all four regions of the femoral neck at three months which did not reach statistical significance and was followed by recovery to baseline levels after 12 months.
Hip resurfacing did indeed preserve BMD in the inferior femoral neck. In contrast, a decrease in the mean BMD in Gruen zone 7 followed uncemented distally fixed total hip replacement. Long term follow-up studies are necessary to see whether this benefit in preservation of BMD will be clinically relevant at future revision surgery.
One of the most common sequelae of total hip replacement (THR) is peri-prosthetic bone loss. Stress shielding is an important cause of this phenomenon according to the principles of Wolff's law. [1] [2] [3] Such bone loss is clinically relevant as it may result in peri-prosthetic fractures and loosening or migration of the implant.
Hip resurfacing arthroplasty is an option for the treatment of arthritis of the hip in young and active patients. This procedure preserves the femoral neck and part of the head and does not invade the femoral canal, thus preserving bone stock. The loading patterns in the femoral neck after hip resurfacing seem to mimic the natural situation, 4,5 although stress shielding seems to occur in the femoral neck according to finite element models. 6, 7 Narrowing of the femoral neck has been described as a radiological feature following hip resurfacing arthroplasty, 8, 9 and might represent adaptive remodelling to stress shielding. However, the literature to date is inconclusive on this subject.
One of the theoretical advantages of hip resurfacing is preservation of the femoral neck which would simplify future revisions in these young patients. However, for this to be true, the preserved bone of the femoral neck needs to be durable and not susceptible to gradual decline. Loss of bone stock in the femoral neck may then predispose to critical narrowing of the neck and to peri-prosthetic fractures. If this transpired the assumed advantages of hip resurfacing would be limited.
Dual energy X-ray absorptiometry (DXA) is a reliable method of evaluating changes in bone mineral density (BMD) and can be applied to the femoral neck. 10 Accordingly it can be used to assess the evolution of changes in BMD after hip resurfacing. Earlier studies using DXA have shown an increase in BMD in Gruen zone 7 11 after hip resurfacing arthroplasty, whereas a decrease in BMD in this zone has been observed after conventional THR. 3, 12 However, these studies were performed with early DXA equipment and today more sensitive software can detect BMD changes in well defined and smaller regions of interest in the femoral neck. Also, these studies were cohort series and a truly randomised comparison between THR and hip resurfacing arthroplasty for changes in BMD has not been previously described. We have performed a prospective THE JOURNAL OF BONE AND JOINT SURGERY randomised controlled trial of hip resurfacing arthroplasty compared with metal-on-metal uncemented THR during which we evaluated changes in BMD in several regions of interest in the femoral neck and proximal femur for the resurfacing procedure and the corresponding region of the calcar in THR.
Patients and Methods
The study was designed following a power analysis based on the work of Lian et al. 13 The minimum number of participants needed in each group to obtain a power of 80% with a significance level of p < 0.05, was determined as 34, with a calculated difference of 2.98% (SD 6.14) in BMD ratio.
Between June 2007 and December 2008, 75 patients were randomly assigned to receive one of two hip implants, either a hip resurfacing arthroplasty (Conserve Plus, Wright Medical Technology, Arlington, Tennessee) or a THR (Zweymüller Metasul, Zimmer Orthopaedic, Warsaw, Indiana). Consecutive randomisation was employed using a computer-generated variable block schedule. The randomisation list was generated by an independent statistician and the resulting treatment allocations were stored in sealed opaque envelopes. Randomisation occurred prior to surgery. Due to the nature of the procedure both the patient and the surgeon could not be blinded to the eventual type of implant but neither the patient nor the surgeon could influence the randomisation process. Patients were informed in detail about the randomisation procedure and accepted the assigned implant in all cases. They were aged between 35 and 65 years old and needed a primary hip replacement because of arthritis, congenital hip dysplasia or post-traumatic arthritis. Patients were excluded if they had a previous history of infection of the hip or other sites, a hip fracture, avascular necrosis with collapse of the femoral head, rapid progressive bone resorption, levels of BMD indicating osteoporosis of the involved hip, or renal failure. Two patients were excluded after randomisation for hip resurfacing since during the operation anatomical deformities were encountered which precluded this procedure and a THR was carried out. Of the randomised patients, 59 had a minimum follow-up of three months. The 29 in group A received a resurfacing implant and 30, group B, an uncemented THR (Fig. 1 ). There were no significant differences between the groups for age and gender (Table I ). The body mass index (BMI) of group A was significantly lower than in group B (Student's t-test, p = 0.048), but this difference was small and considered clinically irrelevant.
Approval from the regional ethics committee from the Radboud University Nijmegen Medical Centre was obtained and all patients provided informed consent.
Surgical technique
Pre-operative digital templating for positioning of the implant (Easyvision, Philips Medical Systems, Eindhoven, The Netherlands) was carried out in all patients. All operations were carried out by one author (JVS) and two other experienced hip surgeons through a posterolateral approach. In group A, the Conserve Plus resurfacing arthroplasty was implanted with both components made of a cast, heat-treated solution-annealed cobalt-chrome alloy. The femoral component was cemented with low-viscosity cement after preparation of the femoral head with multiple subchondral anchor holes, and the hydroxyapatite (HA)-coated acetabular component under-reamed by 1 mm was press-fitted into the acetabulum. The surgical technique has been described in detail before.
14 Cementing around the stem of the femoral component was avoided.
In group B, an uncemented grit-blasted titanium alloy Zweymüller tapered stem and a threaded acetabular component were implanted. As this trial was designed to minimise confounding variables, a metal-on-metal bearing was also used for THR with a Metasul 28 mm diameter modular head and a Metasul lined acetabular component.
Both groups received identical prophylaxis against infection, periarticular ossification and venous thrombosis during the hospital admission and for six weeks after operation. Patients mobilised without any weight-bearing restriction according to their tolerance.
The BMD was measured by DXA (Lunar Prodigy, GE Healthcare, Little Chalfont, United Kingdom) with the software package Encore 2007 version 11.30.062. Measurements were performed two weeks pre-operatively and then at three, six and 12 months after surgery. Since the actual regions of interest could only be defined after implantation of the hip components, these regions were imported from the three-month DXA scan to the preoperatively DXA scan in order to measure baseline BMD levels in the absence of the implant. The patients were positioned supine on the examination table with their feet attached to a positioning device to obtain a standardised reproducible 20° of internal rotation. Mortimer et al 15 found that a range of 15° internal to 15° external rotation yields a precision of 1.7%. The software used in our study was designed to measure the periprosthetic BMD in five regions in the proximal femur in group A and one region (Gruen zone 7) in group B with a mean entrance skin dose of 37 mSv per patient (Fig. 2) .
Tests using phantoms have shown that our DXA scans are accurate for the determination of peri-prosthetic BMD with an error below 1%. 10 In addition, precision and reproducibility of the DXA measurements for each region were assessed on 15 patients (11 male, four female, eight hip resurfacing arthroplasty and seven THR) with a mean age of 53 years (34 to 63). They underwent two sequential DXA examinations of the involved hip, taken on the same day and measured twice by two independent laboratory assistants, with repositioning between each scan. The precision error was then expressed as the coefficient of variation percentage and calculated according to Aldinger et al. 16 The precision in our study (Table II) was adequate and consistent with the literature. 16, 17 Additional quality controls for the DXA equipment were undertaken daily according to the manufacturer's guidelines to verify the stability of the system. No change was observed during the entire study period. Statistical analysis. The BMD data were normally distributed and the differences in each region of interest between the two groups pre-operatively and at each follow-up were analysed using a Student's t-test. The change of the BMD in each region over each observation period was assessed by repeated analysis of variance (ANOVA) for the two groups. For purposes of clarity the mean change in BMD is described as the percentage relative to the pre-operative mean value. Differences were considered statistically significant with a p-value < 0.05. All statistical analyses were performed using SPSS software version 15.0.1 (SPSS Inc., Chicago, Illinois).
Results
The patient characteristics are presented in Table I . As expected, the mean operating time for group A was significantly longer than for group B (Student's t-test, p < 0.001), demonstrating the inherent technical difficulty of the resurfacing procedure. There was no significant difference in pre-operative mean BMD at region 5 which matched Gruen zone 7 11 for resurfacing compared with THR (Student's ttest p = 0.785) ( Table III) . The mean BMD ratios obtained during the 12-month follow-up, compared with the mean baseline levels, are shown in Table IV 
THE JOURNAL OF BONE AND JOINT SURGERY region 4: p = 0.774), together with a subsequent restoration to the baseline pre-operative values at 12 months (Fig. 3) . In contrast, in region 3 of the tip of the peg of the resurfacing arthroplasty, a significant decrease to 92% of the baseline values (ANOVA p < 0.001) was observed at three months which remained 96.6% (ANOVA p = 0.046) of the mean pre-operative value at 12 months.
Due to the nature of a resurfacing arthroplasty compared to a THR, only BMD values of region 5 representing Gruen zone 7 were available for both implants. The mean BMD ratio in region 5 increased to 105.2% of the pre-operative mean values after resurfacing within six months (ANOVA p = 0.012), while in the same region the mean BMD ratio for THR decreased significantly to 82.1% (ANOVA p < 0.001). The actual decrease of 17.9% of the mean BMD ratio in Gruen zone 7 for the THR group was most marked in the first six months after surgery and remained stable thereafter. This pattern of difference in BMD changes between the two implants in region 5 persisted at one year, with a further reduction in the mean BMD ratio for the THR group which remained significantly different from the findings in the resurfacing arthroplasty patients (Student's t-test, p < 0.001). 
Discussion
This prospective randomised controlled study indicates that the normal load transfer through the femoral neck is maintained or restored after hip resurfacing arthroplasty and there is an increase in desnity in the proximal femur. In contrast the BMD was reduced after the uncemented THR used in this study.
These results are in accordance with earlier case control studies, which also reported an increase of BMD in the calcar region to 105% at 12 months 3, 12 and 111% at 24 months in a resurfacing group, 3 and a decrease of 17% in a THR group. However, both earlier studies were non-randomised case control series with the potential for bias in patient selection. In addition, the studies were small and the metal-on-metal HA-bearing was compared with a ceramic-on-polyethylene bearing couple. Our patients were randomised, producing comparable groups with similar demographics (Table I) and bearing couples. The more recent DXA software package used in our study permitted smaller regions of interest to be examined with greater accuracy, as indicated by the low coefficient of variation (Table III) .
The literature is inconclusive regarding the extent to which stress-shielding affects the proximal femoral bone stock after resurfacing. [4] [5] [6] [7] [8] 18 The data from our randomised controlled trial clearly indicate preservation of BMD in the femoral neck after resurfacing arthroplasty and a significant increase of BMD in Gruen zone 7. In the control group of uncemented THRs a significant decrease of the BMD in Gruen zone 7 was identified. This loss of BMD in the proximal femur is a consequence of stress-shielding in distally fixed uncemented THRs. 1, 2, 5, [19] [20] [21] [22] It has to be recognised that the choice of implant plays an important role in the progress of depletion of peri-prosthetic bone stock and thus may have influenced the observed changes in BMD in our study. However, since earlier studies 3, 12 with different types Bone mineral density (ratio in %) 110 Fig. 3 Graph of the mean bone mineral density ratio as a proportion of the pre-operative baseline values (100%) for all regions of interest (ROI) in resurfacing hip arthroplasty (RHA) and total hip replacement (THR).
of resurfacing arthroplasty report similar changes, it appears that evidence is accumulating for true preservation of bone density after this procedure. We have evidence that BMD recovers in the proximal femur after resurfacing arthroplasty, which might be important at a future revision. We recognise the limitations of this study as the follow-up is short. Accordingly, caution must be observed in extrapolating the results at one year of an operation designed to last many years. The significant decrease of region 3 might be iatrogenic as the drill hole for the RHA peg extends beyond the peg itself. We looked at a range of aetiologies for the arthritis of the hip but could not perform any analysis of the subgroups as most patients had osteoarthritis.
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